Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS42000890EBVENSG00000148408.15protein_codingCACNA1BNoNo774Q00975
TVIS30013793HIVENSG00000148408.15protein_codingCACNA1BNoNo774Q00975
TVIS30084602HIVENSG00000148408.15protein_codingCACNA1BNoNo774Q00975
TVIS30077938HIVENSG00000148408.15protein_codingCACNA1BNoNo774Q00975
TVIS30082163HIVENSG00000148408.15protein_codingCACNA1BNoNo774Q00975
TVIS30072769HIVENSG00000148408.15protein_codingCACNA1BNoNo774Q00975
TVIS20002068HPVENSG00000148408.15protein_codingCACNA1BNoNo774Q00975
TVIS20006574HPVENSG00000148408.15protein_codingCACNA1BNoNo774Q00975
TVIS20010570HPVENSG00000148408.15protein_codingCACNA1BNoNo774Q00975
TVIS20006108HPVENSG00000148408.15protein_codingCACNA1BNoNo774Q00975
TCGA Plot Options
Drug Information
GeneCACNA1B
DrugBank IDDB00063
Drug NameEptifibatide
Target IDBE0009351
UniProt IDQ00975
Regulation Typeantagonist
PubMed IDs9825033
CitationsChong PH: Glycoprotein IIb/IIIa receptor antagonists in the management of cardiovascular diseases. Am J Health Syst Pharm. 1998 Nov 15;55(22):2363-86. doi: 10.1093/ajhp/55.22.2363.
GroupsApproved; Investigational
Direct ClassificationPeptides
SMILES
PathwaysEptifibatide Action Pathway
PharmGKBPA449483
ChEMBLCHEMBL1174